logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

RITAMIX (01936): Redemption of funds with a total amount of approximately RM55.254 million

date
20:45 22/10/2026
avatar
GMT Eight
RITAMIX (01936) announced that on September 17, 2026 and October 22, 2026, the Group redeemed funds with a total amount of approximately RM55.254 million through the open market.
RITAMIX (01936) announced that on September 17, 2026 and October 22, 2026, the Group redeemed funds with a total amount of approximately RM55.254 million through the open market.
Related Articles
HK Stock
CNBM (03323): Ningxia Building Materials Group (600449.SH) reported a net profit attributable to shareholders of RMB 123 million for the first three quarters, down 44.32% year on year.
HK Stock
GRAND PHARMA (00512) proposes appointing Deloitte as the new auditor.
US Stock
European molecular testing leader Qiagen (QGEN.US) accepts EQT acquisition offer: 46.50 per share, a 40.3% premium to its July share price.
CNBM (03323): Ningxia Building Materials Group (600449.SH) reported a net profit attributable to shareholders of RMB 123 million for the first three quarters, down 44.32% year on year.
HK Stock
GRAND PHARMA (00512) proposes appointing Deloitte as the new auditor.
HK Stock
European molecular testing leader Qiagen (QGEN.US) accepts EQT acquisition offer: 46.50 per share, a 40.3% premium to its July share price.
US Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.